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Objedves. This study was mtdertaken to determine ,he ability 
of the sigttaf-averaged t&mwdiogram (ECG) to tdeotify evi. 
deuce ef delayed atrial activatiott in patiwts wtth a hbtory 0: 
atrial tibrtnatiw. 
Backgmund. Atrial fibrillation is a reentrant rhythm and 
depends cm atriaf mnductfao delay for its devehpmat. The 
signafaveragia~ tecbniqw is us&d for acutrately meawittg total 
cardiac aclivatitm time% fttciuding delayed low amplitude signals, 
and thus can befp i!Jenttfy the subs+ate for reetdrant arrhytb 
mi4.s. 
Methods. Standard IZ-lead and ngnat-averaged ECGs were 
rewded from 15 ptitntr with a dwumeoted history of prior 
fwoxystttal or dtmnic &al fibrilfaticat and IS age- and disease- 
mat&d mtttrd satbjects witfwt a hir(ory of ahial tibriffatiw. 
Si8ttnl wrr@ng I= performed wing an ortbogottal kad sy*rm 
with the QRS mmpkx as a tripger and the P wave BS a tempt~tr 
for the s@at-avera& pm. Tocnl P wave duratii (IPII 
meatwd befom and after atering wftb a least squares fit filter. 
The P wave cvmfdexes a the tltree bipolar leads were cumbined 
into a vetla c~mf&a& of orthvgwd leads. The total P wave 
duration of tfte fr&idttal uttfdtered and liitered tads and the 
vector mtt&t.%n of Bltered fe& were c&d&d pnd wed for 
analysis. 
rratietits with 
X lead, 157 :22 w. 136 + 17 ms [p < tl.@ll ist%Y~i& 
15Q~23rs.135~15~1o<0.01linthe2krd).A~~. 
Over the part decade, the signal-averaged electracardiogrdm 
(ECG) has emerged as an increasin& valuable tool in the 
evaluation of patients with known or suspected ventriculztr 
arrhythmias. Simsan (I) initially described the presence of 
late potettliafs in the terminal portion of the signal-averaged 
QRS complex in patients with sustained ventricular tachy- 
car&a after mytxardial infarction. Late potentials corre- 
spend in time with delayed cardiac activation and are 
believed to indicate the existence of a substrate for reenttattt 
ventricular arrhythmias (2-5). The presence of QRS ate 
potentials has also been shown to be predictive of both 
electrically indttcib!e ventricular tachycadia zt eleztropbys- 
ialagic study (6-S) and arhythmic events after myocatdial 
infarc:;on (5). 
Although the discovery of QRS late potentials has led to 
imcatant clinical atwlicatians of the sipnal-averaged ECG 
wiih respect to ven&dar tachyarrhythmias. inv&ators 
(9-U) have only recently attempted to study the signal- 
averaged P wave and its relation to atrial arrhythmia. Anal- 
ogous to ventricular tachycardia, atrial fibrillation is thought 
to he due to rcentrcmt mechanisms and thus the atria require 
areas of slow conduction to initiate and maintain the reen- 
trant circuit (U-15). We therefore hypathzsized that the 
signal-averaged KG, hy attenuating bady surface noise, 
would have the sensitivity to detect delayed atrial activation 
in patients with a history of atrial fibrillation. 
The purpose of this sfudy was to employ a signal- 
averaging process using P wave template matching to mea- 
sure total atrial activation and test the hypothesis that atrial 
activation is prolonged in patients with a history of atrial 
fibrillation compared with that in age- and disease-matched 
control subjects. 
Methods 
Patient alc&n. The study was approved by the Institu- 
tional Review Board of our medical center. Informed eon- 
sent was obtained from all patients. The study enrolled two 
g ‘-xps of hospitalized patients at the ccntcr. Patients with a 
documented history of chronic or paroxysmal atrial fibrilla- 
tion were consecutively identified on the medical service and 
were considered eligible for this study if the rhythm at the 
time of signal-averaged ECG recording was nomml sinus 
rhythm. Patients receiving class I antiarrhythmic agents 
were excluded because these agents prolong atrial couduc. 
tion. A control group was selected from hospitalized patients 
with no history of paroxysmal or chronic atrial fibrillation, 
who were then matched with the study group for age and 
underlying heart disease. 
Signal-averaged ECG methodnlogy. The sigaal-averaged 
ECG was recorded with the Predictor system (Corazonix 
Corporation). The subject’s skin was cleansed with alcohol 
and abraded with gauze. An orthogonal lead arrangement 
was used (identical to that in conventional signal-averaged 
ECG recording). Three electrcdc pairs were placed in the 
following locations: 1) X, at the fourth intercostal space in 
both midaxillary lines; 2) Y, in the midclavicular line just 
inferior to the clavicle and to the left of the umbilicus; and 
3) 2, in the fourth intercostal space to the let? of the swaum 
and the vertebral column. Positive electrodes were left, 
anterior and inferior. The okctrodes used were silver/silver 
chloride. The QRS complex was used as the trigger for the 
signal-averaging process; the fiducial point was, however, 
shifted lo the extreme right side of the JMI-ms wiadow to 
expose the P wave and the PR segment. The signal was 
digitized at a Frequency of 2,OCO samples/s with lbbit 
accuracy. This system utilized a cross-correlation ~roaraux 
a sinus P wave template was selected by the opera&r&d P 
wave complexes that did not match the template with a 99% 
correlation coefficient were automatically rejected. Rejected 
P waves included atrial ecfopic beats, excessively noisy 
sinus beats and sinus beats that did not match the template 
because of slight fluctuations in the PR interval occurring as 
a consequence of changes in autonomic tone. The corrcla- 
tion window width was 25 ms and the number of correlations 
to achiave a fit was IO. The P wave complexes were acquired 
until a noise end point ~0.3 WV in the TP segment was 
achieved. This template-matching process ensured acccp 
tance of accurately aliLmcd sinus P waves and rejection of 
ectopic P haves or misaligned sinus P waves (+ 0.5.ms 
jitter). The mean number of beats averaged to achieve a 
Standard ECG met-. A standard Il-lead ECG 
recorded within 24 h of the signal-averaged ECG was rc- 
viewed for each wtient. All standard ECGs were obtaimd a1 
a paper speed of 25mmls and a signal size of 10 mmimV. 
Standard ECG analysis was perfortucd without knowledge 
of the patient’s clinical status. Total P wave durations in all 
limb leads were manually measured and the longest limb lead 
P wave duration was recorded and used for analysis. A P 
wave duration on the standard ECG >110 ms was consid- 
ered abnormal (21). 
Stat&tkti au&ya. Results were expressed as group 
mcan + SD. Comparisons between groups were made with 
the Student t test for paired and unpaired data. A p value < 
0.0s was considered significant. 
ReSUlta 
Shv@ patieuts. The study mup ccmsisted of I5 patients . 
wth a prior history of atrial tibdllatic~ (paroxysmal in 10 
noise end point CO.3 PV was 262 + 204 (range &I to 549) in patients and chronic in 5). Fifteen age- and disease-matched 
patients with atriai fibrillation and 262 f I69 (range 105 to 
&12) in control subjects (p = NS). 
A least squares fit filter with a window width of IO0 ms 
(giving an equivalent high pass cutoff of 29 Hz) was applied 
to the averaged output and the result amplified to improve 
visualization of the low amplihtde components. The least 
squares fit filter operates by fining a smooth curve to each 
segment of prcdclincd length of the ECG. The fitted curve is 
subtracted fmm the orb&d waveform m lewe a residual or 
high pass portion of the ECG signal. The length of the 
segment or window can be adjusted: a shorter segment 
leaves a smaller residual effectively increasing the high pass 
cutoff frequency of the filter. The detailed characteristics of 
the least squares fit filter have been descrilxd elmwherc 
(16). The P wave complexes of the three bipolar leads were 
combined into a vector magnitude by the formula 
ti(X’+Y’+Z% The P wave onset and &et were deter- 
mined manually and perfwnud without knowledge of the 
patient’s arrhythmia status. Tic P wave onset was the first 
xrial dellection from the baseline noise level and the offset 
was the return of the atrial signal to the baseline or onset of 
the QRS complex, whichever was earlier. The total P wave 
duration of the individual unfiltered and filtered X, Y and Z 
leads and tbc vector combination of filtered leads were 
calculated and used for analysis. We chose to measure wal 
P wave duration only rather than. or in addition lo, calcula- 
lion of terminal segment amplitude. The decision lo rncasu~ 
only total P wave duration was based on prior experience 
with QRS signal averaging. where QRS duratiou (rather than 
terminal QRS measurements) is the mcasurcment most 
closely cmrelarcd with abnormal conduction aud arrhythmia 
risk (5,17-19!, the concern that terminal voltage mcasurc- 
meats are poorly reproducible (20) and the absence of any 
noaarbitrmy position to divide the P wave that would be 
predicted to cot~cls.te accurately with delayed atrial a&a- 
lion. 
subjects and pdients with atrial fibrillation are shown in 
Figure I. As a result of amplification and noise reduction, 
unfiltered P wave duration after signal averaging was signif- 
icantly longer than P wave dmaticm measured on the stan. 
dard KG in both groups. In Be patients with atrial fibrilla- 
tion, mean P wave duration increased after signal averaging 
in each of the three oi-thogottal leads from 101 -’ I7 ms to 
132 t 22 (p < 0.01). I35 + 21 (p < 0.01) and 133 ? 23 ms 
(p < 0.01) in the X. Y and 2 leads, respstively. The P wave 
duration after signal averaging increased in the control gmup 
from IO? + 13 msto 114 + 14@-( 0.01). II5 f I5 (p<O.OlJ 
and 114 2 I4 ms (D < 0.01) in the X. Y and 7. leads. 
ECG lead 
Ftgnm 1. P wave duration as msasured by standard and unfiltered 
signal-averaged ekctmardiogmm (ECG). The mean (+ SD) P have 
duration for IS patients with atrial fibrillation (htltrtxd barn) and 15 
control subjects tbt& bars) are shown. The ditTerence in P wave 
duration between the two groups is not statistically significant as 
meawed by standard ECG but P wave dunlion as measured by 
signal-averaged ECG is significantly pmlonged in the X. Y and Z 
leads in patients with atriel fibrillation ret&e to that in control 
Subjects. 
control subjects. The mean age was 68 C I4 yean in the 
atrialfibdlationgmupaml62 2 16 years in thecantml group 
@ = NS). All patients had normal sinus rhythm at the time 
of study. The five patients with a history of chronic atrial 
fibrillation had recently undergone electrical cardioversion 
and at the time of study, two of these patients were receiving 
dl-sotalol, an investigational class 111 antiarrhythmic agent 
with no known effect on attial conduction (22). No other 
patients in either group were receiving antiarrhythmic med- 
ication and no patient had a history of receiving amiodamne. 
Nine patients in the atrial fibrillation group and eight patients 
in the control group had underlying hypertensive bean 
disease, and five patients in each group had ischemic bean 
disease. Four patients in each group had no known under- 
lying hart disease. 
P wave dumtimt on the s&ndard 12.lead ECG. In the 
atrial fibrillation group, the P wave duration measured by 
stathlat’d EC0 ranged from M1 to I20 ms (mean IOI * 17). In 
the contml emup. P wave duration bv standard ECG mneed 
from Otto l!20 & (mean 102 r 13)&g. I). Three patientbin 
each group had a P wave duration >I IO ms. 
Un6itmed and IUlwed ~@&.a- P wave duration. 
Data summarizing the unfiltered P wave duration for each 
orthogonal lead of the signal-averaged ECG for control and 
respectively. 
The effect of filtering was an increase in measured P w.ve 
duration relarivetoun6kered Pwaveduration inbathgmups 
because of amplification ;r.d enhanced detecticn of low 
amplitude signals. We cannot entirely exclude the possibility 
that the least squares titter caused ~mne prolongation. The 
man P wue duration in patients with atrial fibrillation 
increased fmm 132 * 22 ms to 151 2 23 ms @ < 0.01). from 
I35 -t 21 to I57 C 22 ms (p c 0.01) and from 133 + 23 to 
154 2 23 ms (p i 0.01) in the X, Y and 2 leads, respectively. 
In the costml group, P wave duntion increased atIer filter- 
ing from 1 I4 + I4 to 130 f 19 ms (p < 0.01) in the X lead, 
from I I5 + I5 to 136 z 17 ms (p < 0.01) in the Y lead and 
fmm II4 + I4 to 135 + I5 ms (p < 0.01) in the 2 lead. 
Sigttabaverqed P wave dtuatkm in the two gmups. hi 
each of the orthogonal leads, the tttttiltered P wave duration 
was significantly :onger in the patients with a history of atrial 
fibrillation than in the matched control subjects. In each 
lead. the mean tmtiltered P wave duration in the atrial 
fibrillation group exceeded the mean unfiltered P waw 
duration in the control group (132 i 22 vs. 114 + 14 ms [p C 
0.031 in the X lead. I35 +_ 21 vs. ll5 * IS ms ID < 0.031 in the 
Y leid and 133 + 23 vs. 114 5 14 ms [p < O.i31 in the-Z lead 
[Fig. II). Within beth the attial fibrillation and control 
soups. there was no significant difference in P wave dura- 
iion is measured in eaci of the three orthogonal leads. 
Filtered P wave duration was longer in pients with atrial 
fibrillation than in the control group (mean 151 f 23 vs. 
130 5 19 ms la < 0.011 in the X lead. 157 c 22 vs. I36 + 
17 ms [p < O.oi] in the i’ lead and I54 & 23 VS. 135 2 IS ms 
[p < 0.011 in the Z lead [Fig. 21). Within each group, there 
was no skniiicant difference in P wave duration as measured 
in each 07 the three orthogonal eads. 
The three orthogonal eads were combined into a vector 
composite lead. A&n. the mean P wave duration in the 
atrial fibrillation group was longer by 16% than that in the 
control group (162 f I5 vs. 140 * I2 ms Ip < 0.011 [Fig. 21). 
Examples of signal-averaged vector combinations of orthag- 
onal leads are shown in Fiettre 3. 
Lnsitlvi~y and q~~lficlty of P wave duraticm for ahisl 
fibrillation. ‘Tile P “we duration of the filtered vector cmn- 
posite leads for all patients with atrial fibrillation and contmi 
subjects was used todetermine the sensitivity and specificity 
of P wave signal averaging for identifying patients with B 
Figurel. Mean + SD P wave duration measured by signal-averaged 
elcetmeardiogmm (EC@ in each of three crthcgcnal leads and their 
vector combinatbn after filtering. There is significant P wave 
pmlongation i the IS patients with atria1 fibrillation (hat&d bars) 
relative to that in the IS control subjects @Ia& bars) in each 
individual lead and in the vector composite. 
history of atria1 fibrillation (Fig. 4). A P wave duration 
al55 ms yielded a sensitivity of 80% (12 of I5 patients), 
specificity of 93% (14 of I5 patients) and a positive predictive 
value of92% (I2 of I3 oatients) for identifvinn oalicnts with . . -. 
a history of atrial fibrillation. 
Discussion 
The association of QRS late potentials with ventricular 
tachycardia has allowed the signal-averaged ECG to play an 
increasingly important role in the noninvasive evaluation of 
a wide variety of patients at risk for ventricular arrhythmias. 
The potential uses ofihe signal-averaged RCG for evaluating 
patients with a propensity for atrial arrhylhmias have not 
been adequately explored. Our results suggest that the 
signal-averaged ECG can be used lo demonstrate prolooget’ 
atrial conduction not apparent on the standard ECG as a 
result of better detection of low amplitude signals in patients 
with a history of atrial fibrillation. 
Using a system designed to analyze total atrial aclivation 
time, we found that the signal-averaged P wave duration was 
significantly longer in patients with prior atrial fibrillation 
than in age- and disease-matched control subjects. Signal- 
averaged P wave duration was prolonged in unfiltered or- 
thogonal leads and filtered orthogonal and vector leads. 
Maximal ditTerences that yielded a clinically useful sepata- 
don between patients and control subjects were evident on 
the vector lead. The signal-averaging process utilized in this 
study allowed detection and accurate delineation of small 
atrial signals in the early and. more important, tbc late 
coawonents of the P wave not aooarcnt on the standard 
EC& 
Study rationale. The mechanism of atrial fibrillation is 
thou& to involve reentry. The model developed bv Moe 
(14) for atrial fibrillation involving multiple waveiets of 
conduction produced by multiple atrial sites of rate- 
dependent conduction block has been confirmed by record- 
ing conduction patterns during induced episodes of atrial 
fibrillation in the cattine model and in humans (13.15). Just as 
the presence of QRS late potentials indicates slowed con- 
duction and the anatomic substrate for reentrant ventricular 
arrhythmias (23-2.9, a delay in atrial conduction measured 
on the signal-averaged ECG may reveal the physiologic 
substrate for alrial fibrillation. 
The process of signal averaging atten~tes electrical noise 
and facilitates detection of low amplitude signals such as 
those rellectiag regions of delayed myocardial activation. It 
was our hypothesis that P wave signal averaging would 
provide a rapid noninvasive method of identifying alrial 
conduction delay. 
Atrial fibrillation is most commonly seen in patients with 
underlying struclural heart disease. including hypertensive 
heart disease, rheumatic valvular disease, coronary artery 
disease, pulmaoary embolism and pericardial disease. Al- 
though these clinical stales identify patients at increased risk 
for the development of atrial fibrillation. there is oe reliable 
method for sl&ifying the relative risk of developing alt’ial 
fibrillation within this larae arouo of oalients. Because the 
development of alrial Rb~llaiion is associated with a signif- 
icantly increased risk of morbidity and mmtalily, a mcaos of 
identifying these patients well before the onset of alrial 
fibrillation could lead to more frequent su~elllallce of these 
patients and possibly a more aggressive approach to the 
treatment of their underlying cardiovascular disorder or a 
prophylactic intervention for atria1 fibrillation. Even if it 
were oat possible to avert the onset of auial fibrillation, 
therapeutic strategies could be tailored to minimize the 
associated morbidity. 
&vim13 studifs using ibe staadard ECG. In an attempt to 
identify a subset of patients at particularly bii risk for 
developing atrial fibrillation or flutter after aortocoronary 
bypass grafting, Buxton and Josephson (26) observed the 
postoperative course of 99 patients undergoing this opera- 
tion. TL presence ofan intraatrial conduction defect did not 
identify patients at risk for postoperative attial fibrillation or 
flutter. These invesligators we:: able to derive a predictor of 
postoperative atrial fibrillation or flutter by measuring tot4 P 
wave duration obtained from the simultaneous recording of 
lhe three staodard limb leads, but the poor specificity Ii&ted 
the usefulness of this technique. 
P wave a&y& IIS@ l&e sign&averaged ECG. A major 
obstacle to the application of signal averaging to the study of 
atrial arrhythmias has been the variP.ble temporal relation 
Ftrr 3. Examples of measured P waver from the vector 
combination of filtered orthogonal leads. A, Signal- 
averaged electrocardiogram (SAECC) fmm a control sub- 
ject with a measured ? wave dumtioo (Dur) af I16 mr. II. 
Recording from a patient with atrial Bbrillation who had a 
P wave duration oft62 ms. LstSqr = least squares fit fitter: 
Rata = protocot. 
A 
between atrial and ventricular depolarization. This vaciabil- 
ity is influenced by changes in autonomic tone tie to 
respiration. and it results in slight fluctuations in the PR 
interval over time. The commordy used signal-averaging 
method is a temporal prwxss that utilizes the QRS complex 
as the reterence point or trigger, and as t!te template for 
acceptaace or rejection during the &ml-averaging dcqttisi- 
lion. Although acceptable for measurement of the QRS 
complex, this method of signal averaging is tmt optimai for 
analysis of the P wave because the variability of the PR 
interval (and thus the relation of the P wave to the QRS 
complex) over the course of rhe sigaalavetxged acquisition 
cattse~ an unacceptable amount ofjitter, making interpreta- 
tion and detection of ihigh frequency signals of the P wave 
unreliable. We modified tire conventianal signal-averaging 
process on a commercially available sy~lem by retaining the 
QRS complex as the trigger but using the P wave as rha 
template. Using this method, all P waves that did not match 
the exact timing of the selected template were rejected and 
proper aligmttent was ensured. thereby reducing jitter to 
20.5 ms. Extremely accurate alignment was achieved with a 
cross-correlation hmction that required a coefficient of 0.99. 
In addition, the filler applied to the signal-averaged P wave 
was designed to limit any signal distortion or oscillation that 
can result from the bidirectional filtering commonly used for 
QRS signal averaging ifit is centered at the QRS complex. 
The least sqttaras lit filter is a high pass digital filter with a 
linear phase response It markedly diminishes ringing com- 
pared with unidirectional filters and will not carry any QRS 
energy into the P wave. 
17oi 
Low studies. More recently, Fukunami et al. (11) re- 
ported success in using the signal-averaged ECG to identify 
patients at risk for ahial fibrillation. These investigators 
recorded signal-averaged ECGs from a group of patients 
with paroxysmal atrial fibrillation and a gmup of age- and 
disease-matched control patients using a custom-designed P 
wave-triggered signal-averaging system. There were signif- 
icant differences in the measured signal-averaged P wave 
variables, including total P wve duration between the atrial 
fibrillation and control groups. However, excessive overlap 
between patients and control subjects limited the clinical 
utility of the findings reported in their study. The methodol- 
ow used by these investigators differs sianiticantly &am that 
uskd in oe; study. B&e their method of P w&e filtering 
utilized an analog unidirectional filter. it is possible that 
some P wave durations could have been extended by a 
filter-ringing artifact. Furthem~ore, their method ofP wave 
cor&tion was not woned. It is unclear whether better 
filtering or improved &relation, or both, aould have en- 
hanced the separation of signalaeraged P we duratioii 
between the atria1 fibrillation and control groups. 
Figure 4. The P wave duration of vector combination of filtered 
orthogonal leads for all IS patients with atria1 fibrillation and the 15 
control subjects. A Pwave duration slS5 ms idendAedptientS with 
a history of atrial fibrillation with e mritivity of 8opb and a 
specificity of 93%. 
lniriol sfudy. In the first reported attempt to signal aver- 
age P waves, Engel et al. (9) compared P wave durations in 
three groups: normal subjects, patients with a history of 
paroxysmal or recently converted atrial fibrillation and con- 
trol patients with a history of sustained ventricular tachycar- 
dia, congestive heart failure or acute myocardial infarction. 
These investigators attempted to identify low amplitude 
atrial signals by subtracting unfiltered f’mm filtered P wave 
duration. Although the filtered P wave duration was pro- 
longed in comparison with the value in normal subjects, it 
was not longer in the atrial fibrillation group than in the 
control group. Filtered minus unfiltered P wave duration was 
not significantly diierent in any of the three groups, leading 
the investigators to conclude that the signal-averaged ECG 
was not helpful in identifying patients with a history of atrial 
tibtillation. The limitations in this initial attempt to signal 
werage P waves were acknowledged by Engel (IO) in a 
subsequent review of the signal-averaged ECG. In addition 
to the previously mentioned differences in signal-averaging 
methodology (use of the P wave rather than the ORS 
Staaord et al. (12) found that signal-aver&d P wave 
duration was simdficantly but minimally longer in 9 patients 
with paroxys&l atrial fibrillation than in iS ag&atchal 
control subjects. However, when the data were dichoto- 
mized, signal-averaged P wave duration did not distinguish 
between the two groups. Although these investigators wed 
the P wave as a template, correlations were made visualIy, it 
is therefore possible that inadequate correlation might have 
increased jitter, thus limiting the detection of high frequency 
atrial sigwds and creating ;rcatcr overlap between patients 
with atrial fibrillation and control subjects. 
LimiWbns of the pmat ahay. This present investipa- 
tion has several limitations. I) Although notte of the patients 
with atrial fibrillation had recently received class I anti- 
arrhythmic drugs and none had ever received amiodamne, 
two~paticnts w&e receiving the class 111 drug dl-sot&l. 
However, dl-sotalol has no known effects on atrial conduc- 
tion (22) and thus should not have altered our Rndings. When 
the two patients who were receiving dl-sotalol and their age- 
and disease-matched control subjects were excluded from 
data analysis, the results were unchanged. 2) Patients with 
oaroxysmal atrial fibrillation were grouped with patients 
with chronic atrial Rbrillation who h&l r&ently undergone 
electrical cardioversion. Although these are not identical 
patient groups. a previous invest&&n (27) has shown that 
these patients share similar electrophysiologic abnormaii- 
ties, as determined by direct cardiac recordings. 3) Macar- 
complex ai; template and use of a least squares rather t&n disc recordings w&not available to correla~ atrial activa- 
a bidirectional filter to eliminate distortion of the P wave), tion times with the signal-averaged P wave memurements. 
diffccwnces in patient selection may have contributed to the Although the increased P wave duration seen in both patient 
contrast between our results and those reported by Engel et groups aRer filtering was attributed to ampliication and 
al. (9). Specifically, we excluded patients receiving class I detection of low amplitude atrial signals, we cannot exclude 
antiarrhythmic agents (which are known to prolong atrial the possibility that the least squares tilter itselfcawed some 
activation)and selectedacontrolamuo that was matched for increase in the measured P wave duration by smeadbu the 
age and underlying heart disease: signal. 4) The number of patients studied~w~ &&ely 
small. 5) Echocwdiogmphic data to correlate atrial dimen- 
sion with measured standard and signal-avenged ECG dlt:, 
were not available. 
Condusimu. In the present study, the signal-avenged P
wave duration was lonp,er in patients with mior chronic UT 
paroxysmal atrial fibrktion than in ag;- and diseare- 
matched control subjects. Delayed atrial conduction in pa- 
tients with a history of atrial fibrillation was not evident on 
the standard 1%lead ECG. A signal-averaged P wave dun- 
tion 2155 ms had good sensitivity and excellent swcificitv 
for identifying patients with a h&tory of a!rial fidrillatio~. 
Our results surest that the sknal-averwed ECG P wave 
duration is a skp!e and rapid kminvasik method ohtain- 
able with commercially available signal-averaging systems. 
This method merits further prospective study in lam_e ptiz! 
groups 10 determine its clinical role in identifying parienrs at 
risk for developing atrial fibrillation. 
